HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Tumor immunology is a specialized field of study within immunology that focuses on understanding the interactions between the immune system and cancer cells. The human immune system plays a crucial role in recognizing and eliminating abnormal cells, including cancerous ones. Tumor immunology explores the complex mechanisms by which tumors evade immune surveillance and develop strategies to escape destruction. One key aspect of tumor immunology is the identification of specific molecules expressed on the surface of cancer cells, known as tumor antigens. These antigens can trigger an immune response, leading to the activation of immune cells such as T cells. However, tumors can employ various mechanisms to suppress or evade this immune response, allowing them to persist and grow. Researchers in tumor immunology aim to develop strategies to enhance the body's natural ability to recognize and eliminate cancer cells. Immunotherapies, a rapidly advancing area of cancer treatment, harness the power of the immune system to target and destroy tumors. Checkpoint inhibitors, adoptive cell therapies, and cancer vaccines are examples of immunotherapeutic approaches that have shown promising results in certain cancers. Understanding the intricate interplay between the immune system and tumors is crucial for the development of more effective and targeted cancer therapies. Ongoing research in tumor immunology continues to uncover novel insights into the complex dynamics of the immune response to cancer, paving the way for innovative treatments that hold the potential to revolutionize cancer care.
